Are Wall Street Analysts Bullish on Danaher Stock?

Washington, DC-based Danaher Corporation (DHR) is a leading global life sciences and diagnostics innovator, helping solve many of the world’s most important health challenges. It focuses on areas such as Life Sciences, Diagnostics, Biotechnology and more. Valued at $146 billion by market cap, Danaher employs over 61,000 people and operates in 50 different countries and 700 locations across the globe.

The healthcare giant has significantly underperformed the broader market over the past year. DHR stock has plummeted 15.7% over the past 52 weeks and 11.3% on a YTD basis, lagging behind the S&P 500 Index’s ($SPX) 23.5% surge over the past year and SPX’s 4% gains in 2025.